We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1026
DELISTED
Allakos
ALLK
$9K ﹤0.01%
104
KOD icon
1027
Kodiak Sciences
KOD
$2.62B
$9K ﹤0.01%
100
RETA
1028
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$9K ﹤0.01%
62
ACAD icon
1029
Acadia Pharmaceuticals
ACAD
$4.35B
$8K ﹤0.01%
317
BNS icon
1030
Scotiabank
BNS
$106B
$8K ﹤0.01%
130
EDIT icon
1031
Editas Medicine
EDIT
$411M
$8K ﹤0.01%
133
IOVA icon
1032
Iovance Biotherapeutics
IOVA
$2.19B
$8K ﹤0.01%
291
SWTX
1033
DELISTED
SpringWorks Therapeutics
SWTX
$8K ﹤0.01%
92
ARNA
1034
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8K ﹤0.01%
119
AGIO icon
1035
Agios Pharmaceuticals
AGIO
$2.2B
$7K ﹤0.01%
122
-16
-12% -$895
ALKS icon
1036
Alkermes
ALKS
$8.79B
$7K ﹤0.01%
299
ALLO icon
1037
Allogene Therapeutics
ALLO
$604M
$7K ﹤0.01%
279
ARVN icon
1038
Arvinas
ARVN
$530M
$7K ﹤0.01%
94
KB icon
1039
KB Financial Group
KB
$41.5B
$7K ﹤0.01%
150
-20
-12% -$998
SAGE
1040
DELISTED
Sage Therapeutics
SAGE
$7K ﹤0.01%
116
TPTX
1041
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$7K ﹤0.01%
95
INSM icon
1042
Insmed
INSM
$22.7B
$6K ﹤0.01%
204
NKTR icon
1043
Nektar Therapeutics
NKTR
$2.41B
$6K ﹤0.01%
24
PTCT icon
1044
PTC Therapeutics
PTCT
$6.29B
$6K ﹤0.01%
139
RLAY icon
1045
Relay Therapeutics
RLAY
$4.06B
$6K ﹤0.01%
169
ITCI
1046
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
151
KRTX
1047
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6K ﹤0.01%
54
AXSM icon
1048
Axsome Therapeutics
AXSM
$12.3B
$5K ﹤0.01%
70
BCRX icon
1049
BioCryst Pharmaceuticals
BCRX
$2.43B
$5K ﹤0.01%
332
KYNB
1050
Kyntra Bio
KYNB
$28.5M
$5K ﹤0.01%
7

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.